Last month the FDA approved the first treatment for late-stage metastatic melanoma that's shown increased patient survival - Yervoy (ipilimumab). It's also had promising results when combined with chemotherapy in previously untreated patients with inoperable melanoma. However, there is a risk of for severe immune reactions. Read more about the risks and benefits of Yervoy.

Popular Posts

Followers

Privacy Notice

This blog uses a third party (Google Adsense) for advertising. Google may use cookies to gather information on browser preferences, including the ne DART double-click cookie. Users may opt out of the use of the DART cookie by visiting the Google ad and content network privacy policy.